Serum cystatin C concentration does not predict advanced liver disease in children with chronic hepatitis B

2004 ◽  
Vol 347 (1-2) ◽  
pp. 227-228 ◽  
Author(s):  
Dariusz M Lebensztejn ◽  
Elżbieta Skiba ◽  
Maciej Kaczmarski ◽  
Jolanta Tobolczyk ◽  
Alicja Koput ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Liver Disease ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Cystatin C ◽  
Serum Cystatin C ◽  
Advanced Liver Disease ◽  
Serum Cystatin

scholarly journals Association between serum Cystatin C and renal injury in patients with chronic hepatitis B

Medicine ◽  
2020 ◽  
Vol 99 (32) ◽  
pp. e21551
Author(s):  
Hui Zheng ◽  
Haidong Liu ◽  
Anhua Hao ◽  
Min Zhang ◽  
Dexin Wang
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Cystatin C ◽  
Renal Injury ◽  
Serum Cystatin C ◽  
Serum Cystatin

Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

2004 ◽  
Vol 351 (15) ◽  
pp. 1521-1531 ◽  
Author(s):  
Yun-Fan Liaw ◽  
Joseph J.Y. Sung ◽  
Wan Cheng Chow ◽  
Geoffrey Farrell ◽  
Cha-Ze Lee ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Liver Disease ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Advanced Liver Disease

scholarly journals Management of chronic hepatitis B before and after liver transplantation

2017 ◽  
Vol 9 (1) ◽  
pp. 79-84 ◽  
Author(s):  
B Wang ◽  
K Agarwal ◽  
D Joshi
Keyword(s):  
Liver Transplantation ◽  
Chronic Hepatitis ◽  
Liver Disease ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Public Health Problem ◽  
Global Public Health ◽  
Chronic Hepatitis B Infection ◽  
Before And After ◽  
Related Liver Disease

Chronic hepatitis B infection is a global public health problem associated with significant morbidity and mortality. Persistent infection may evolve to liver cirrhosis and hepatocellular carcinoma, and hepatitis B-related liver disease is a common indication for liver transplantation. Patients with advanced liver disease should be treated with antiviral therapy which may result in clinical improvement. The management of patients after liver transplant then focuses on preventing hepatitis B recurrence in the graft. With the introduction of prophylactic treatment, patient and graft survival has improved significantly. In this review, we will discuss the management of patients with hepatitis B-related cirrhosis, both compensated and decompensated. We also review the management of hepatitis B after liver transplantation.

Sign in / Sign up

Export Citation Format

Share Document